Industry Calls for Tougher Sanctions to Deal with Counterfeit Medicines

The European Commission says it has received about 100 submissions from pharmaceuticals manufacturers and patient groups as part of its consultation exercise to stop the counterfeit production of medicines. Cefic, in its response, has told the commission that rather than draw up new regulations the effective enforcement of existing legislation could significantly improve the current situation.   “If properly enforced with severe penalties for offenders, [it] would significantly reduce the escalating risk driven by globalisation and hyper-competition in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers